Equivalence of ELISpot assays demonstrated between major HIV network laboratories (Q33778327)

29 July 2017

Equivalence of ELISpot assays demonstrated between major HIV network laboratories (English)

1 reference

29 July 2017

21

M Juliana McElrath

1 reference

29 July 2017

Yunda Huang

2

0 references

Pontiano Kaleebu

17

object named as

Pontiano Kaleebu

1 reference

29 July 2017

22

Josephine H Cox

1 reference

29 July 2017

19

Richard Koup

1 reference

29 July 2017

18

Steven G Self

1 reference

29 July 2017

Dilbinder K Gill

1

1 reference

29 July 2017

Gail L Levine

3

1 reference

29 July 2017

Anna Sambor

4

1 reference

29 July 2017

Donald K Carter

5

1 reference

29 July 2017

Alicia Sato

6

1 reference

29 July 2017

Jakub Kopycinski

7

1 reference

29 July 2017

Peter Hayes

8

1 reference

29 July 2017

Bridget Hahn

9

1 reference

29 July 2017

Josephine Birungi

10

1 reference

29 July 2017

Tony Tarragona-Fiol

11

1 reference

29 July 2017

Hong Wan

12

1 reference

29 July 2017

Mark Randles

13

1 reference

29 July 2017

Andrew Raxworthy Cooper

14

1 reference

29 July 2017

Aloysius Ssemaganda

15

1 reference

29 July 2017

Lorna Clark

16

1 reference

29 July 2017

Blake Wood

20

1 reference

29 July 2017

John Hural

23

1 reference

29 July 2017

Jill Gilmour

24

1 reference

29 July 2017

language of work or name

English

0 references

publication date

14 December 2010

1 reference

29 July 2017

1 reference

29 July 2017

5

1 reference

29 July 2017

12

1 reference

29 July 2017

e14330

1 reference

Creative Commons CC0 License

29 July 2017

start time

14 December 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

cites work

"MIATA"-minimal information about T cell assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

Multiple functions of human T cells generated by experimental malaria challenge

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

The role of IFN-gamma Elispot assay in HIV vaccine research

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag c

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

The global HIV vaccine enterprise.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

Medicine. The need for a global HIV vaccine enterprise

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

A concordance correlation coefficient to evaluate reproducibility

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001861

Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity

4 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014330

Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014330

Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014330

Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014330

Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC

21 January 2018

1 reference

12 December 2020

Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay

1 reference

12 December 2020

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

1 reference

12 December 2020

Simple improved confidence intervals for comparing matched proportions

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0014330

Identifiers

DOI

1 reference

29 July 2017

0 references

1 reference

29 July 2017

1 reference